Faculty profile

Lucia Nappi

ResearcherUrologic SciencesUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Lucia Nappi

Researcher

Urologic Sciences

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
26 publications in the last five years, latest in 2026.
Senior (last) author on 8 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adolescent And Young Adult Cancer Patients Biomarkers Chemotherapy Sparing Treatments Early Diagnosis Germ Cell Tumors Microrna371 Plasma Micro-Rnas Quality Of Life

Latest papers

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.
Nature communications · 2026
Novel High-Dose Chemotherapy Regimens in Relapsed/Refractory Germ Cell Cancer: Have We Made Progress?
Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.
The Journal of urology · 2025

All 57 publications

Latest funding

Detection of early relapse using circulating miR371a-3p in patients with clinical stage I testicular germ cell tumors
CIHR · 2021 · Nominated PI
$76,500

All 1 grants and awards

57 publications.

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Müller DC, Murtha AJ, Bacon JVW, Stephenson M, Wells C, Vasquez-Rios C, Rostin K, Rebane L, Schönlau E, Nikkola J, Alimohamed N, Basappa NS, Finch D, Ko JJ, Lavoie JM, Nappi L, Noonan K, Ong M, Ozgun G, Parimi S, Soleimani M, Sridhar SS, Toren P, Winquist E, Bernales CQ, Koudjanian M, Atwal J, Fung E, Khan L, Eigl B, Othman D, Bismar TA, Wang G, Merza R, Papadakis AI, Spatz A, Kollmannsberger C, Maurice-Dror C, Annala M, Chi KN, Vandekerkhove G, Wyatt AW, Eigl BJ

Nature communications2026

DOI: 10.1038/s41467-026-69927-7 PMID: 41760649

Novel High-Dose Chemotherapy Regimens in Relapsed/Refractory Germ Cell Cancer: Have We Made Progress?

Kollmannsberger C, Nappi L, Nichols CR

Clinical cancer research : an official journal of the American Association for Cancer Research2026

DOI: 10.1158/1078-0432.ccr-25-3334 PMID: 41231121

Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.

Hu B, Alsyouf M, Farkouh A, Cary C, Masterson T, Einhorn L, Adra N, Boorjian SA, Kollmannsberger C, Schuckman A, So A, Black PC, Bagrodia A, Skinner E, Alemozaffar M, Brand T, Eggener S, Pierorazio P, Stratton K, Nappi L, Nichols C, Daneshmand S

The Journal of urology2025

DOI: 10.1097/ju.0000000000004561 PMID: 40203124

Machine Learning Model Integrating Computed Tomography Image-Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer.

Ozgun G, Abdalvand N, Ozcan G, Nip KM, Khazamipour N, Rahmim A, Bell R, MauriceDror C, Soleimani M, Chi K, Eigl BJ, Nichols C, Kollmannsberger C, Yuan R, Nappi L

JCO clinical cancer informatics2025Senior author

DOI: 10.1200/cci-25-00105 PMID: 40854169

Testicular cancer.

Chavarriaga J, Nappi L, Papachristofilou A, Conduit C, Hamilton RJ

Lancet (London, England)2025

DOI: 10.1016/s0140-6736(25)00455-6 PMID: 40451233

Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma.

Munzur AD, Bacon JVW, Fishbein F, Herberts C, Donnellan G, Bernales CQ, Parekh K, Vandekerkhove G, Müller DC, Liao YJR, Stephenson M, Nappi L, Khalaf D, Maurice-Dror C, Chi KN, Eigl BJ, Kollmannsberger C, Soleimani M, Wyatt AW

NPJ precision oncology2025

DOI: 10.1038/s41698-025-00965-y PMID: 40514379

Key Updates in Testicular Cancer: Optimizing Survivorship and Survival.

Bagrodia A, Haugnes HS, Hellesnes R, Dabbas M, Millard F, Nappi L, Daneshmand S, Kollmannsberger C, Einhorn LH

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting2025

DOI: 10.1200/edbk-25-472654 PMID: 40324110

Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumors.

Angeles A, Khazamipour N, Dhillon G, Janfaza S, Oo HZ, Ozgun G, Moeen A, Nichols C, Kollmannsberger C, Carey MS, Nappi L

PloS one2025Senior author

DOI: 10.1371/journal.pone.0322477 PMID: 40343905

MicroRNA as a Liquid Biomarker to Detect Malignancy in Small Testicular Masses.

Chavarriaga J, Langleben C, Lobo J, Nappi L, Yousef GM, Ozcan G, Khazamipour N, Tavares NT, Prassas I, Dimitrakopoulos L, Yuan X, Bobrowski A, Prendeville S, Anson-Cartwright L, Jeronimo C, Jarvi K, O'Malley M, Leão R, Lajkosz K, Hamilton RJ

European urology oncology2025

DOI: 10.1016/j.euo.2025.08.004 PMID: 40998685

Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.

Soleimani M, Thi M, Janfaza S, Ozcan G, Mazurek S, Ozgun G, Maurice-Dror C, Eigl B, Chi K, Kollmannsberger C, Nappi L

Scientific reports2025Senior author

DOI: 10.1038/s41598-025-99376-z PMID: 40295702

Something wrong or missing on this profile? Suggest a correction

Lucia Nappi

Research

Latest papers

Latest funding

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Novel High-Dose Chemotherapy Regimens in Relapsed/Refractory Germ Cell Cancer: Have We Made Progress?

Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.

Machine Learning Model Integrating Computed Tomography Image-Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer.

Testicular cancer.

Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma.

Key Updates in Testicular Cancer: Optimizing Survivorship and Survival.

Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumors.

MicroRNA as a Liquid Biomarker to Detect Malignancy in Small Testicular Masses.

Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.

Detection of early relapse using circulating miR371a-3p in patients with clinical stage I testicular germ cell tumors

Frequent collaborators

Martin Gleave

Kim Chi

Alan So

Gang Wang

Bernhard Eigl

Amina Zoubeidi

Christina Canil

Gregory Pond

Sebastien Hotte

Yuzhuo Wang

Xuesen Dong

Robert Hamilton

Piotr Czaykowski

Eric Winquist

Paul Toren

Michael Ong

Nicholas Power

Andrew Weng

Arman Rahmim

David Huntsman

Colin Collins

John Kuruvilla

Artem Cherkasov

Christian Steidl

Keith Jarvi

Srikala Sridhar